Abstract
Keywords
Antibiotic overusage Pediatrics DDD-antibiotic consumption Ceftriaxone
Introduction
The increasing prevalence of antibiotic-resistant bacteria is a major health-care problem worldwide (1). The relationship between emergence of resistance and antibiotic use and misuse is well recognized (2).
The overuse of antibiotics and poor compliance with infection control measures have been identified as the two major reasons for increasing antimicrobial resistance (1, 3, 4). Some evidences show that antibiotics are prescribed inappropriately in up to 50% (3, 5). Similar pattern of unnecessary antibiotics prescription was reported in children, especially by general practitioners (6).
The total amount of an antibiotic used in a particular geographical area over a certain period of time is among of major causes of occurring antibiotic resistance (2, 7).
Problems associated with the overuse of antibiotics include development of antibacterial resistance, raising the burden of chronic diseases, increasing costs of health services, and the development of side effects (e.g. gastrointestinal effects)(8).
The considerable amount of antibiotics misuse in children is one of the most important global public health issues (9).
Different methods of measuring antibiotic use are applied in the different studies (10-12). World Health Organization (WHO) recommends DID (daily defined dose per 100 bed-days Inhabitant per day) as a standard tool for measurement of antibiotic consumption in inpatient setting. Defined daily dose (DDD) is the average maintenance dose per day for a drug used in its main indication in adults (10, 12).
Knowledge of prescription patterns is an important tool in rational drug therapy. Children were subject to increasing exposure to antibiotics throughout the 1980s, so rational drug therapy is especially important for this age group (13).
Previous studies have demonstrated a large variation in pattern of antibiotic use in different countries (14, 15). Since there was not any information regarding the antibiotics usage pattern in the north of Iran, this study was conducted to address this issue in our setting.
Experimental
Setting
This cross-sectional study was performed in Buali-Sina hospital; an educational university- affiliated hospital consisted of 6 wards with 220-beds, in north of Iran, Sari. The inclusion criteria were all of the neonates, infants and pediatrics who hospitalized during 22 Sep 2010 – 21 Sep 2011 and received any antibiotics.
Records of patients were studied by using the health information system (HIS) database. Data of fall and winter seasons (22 Sep 2010 – 19 Mar 2011) was separately gathered and analyzed from spring and summer seasons (20 Mar 2011 – 21 Sep 2011). Data of different wards including Neonatal, NICU, PICU, Pediatrics and Pediatric surgery were separately extracted and analyzed.
Drug consumption data were expressed as defined daily doses (DDD) per 100 inhabitants per day (DID). In order to calculate DID, ATC (Anatomical Therapeutic Chemical) codes and DDD for each antibiotic were obtained from WHO website (http://www.whocc.no/atc_ddd_index/?code=J01DH51 ; ATC/DDD Index 2012; last updated: 2011-12-19; accessed: 2012/11/05) (16). The following formula was used to calculate DID (17).
DDD per100 inhabitant per day (DID) =(Total consumption in DDDs x 100)/(Covered inhabitants x Days in the period of data collection).
Statistical analysis
The HIS data was transferred to Excel program for calculation of DID. SPSS 16 software was used for statistical analysis. Independent samples t-test was used to compare the quantitative variables including “days of hospitalization”, and “amount (mg) of antibiotics used” between two time periods.
p-value less than 0.05 were considered as a significant difference.
Results
A total of 4619 in-patients records during 1 year of study including 2494 patients in fall and winter seasons and 2125 patients in spring and summer seasons were evaluated.
The numbers of hospitalized patients in different wards were showed in Table 1. During 1 year of study, most hospitalized patients were in Pediatric ward (43.9 %) followed by Surgery, Neonate, NICU and PICU wards.
The result of DID (DDD/100 inhabitant/day) calculation for each antibiotic in cold and warm seasons was demonstrated in Chart 1.
The highest DID value were obtained for ceftriaxone (21.7), ampicillin (6.05) and vancomycin (4.7), while the lowest value was for gentamicin (0.01).
Bed-days of hospitalized patients in different wards
| p-value | Total | Spring & Summer | Fall & Winter | Hospital | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Bed-days | Day-Stay (Mean±SD) | Number of patients(%) | Bed-days | Day-Stay (Mean±SD) | Number of patients(%) | Bed-days | Day-Stay (Mean±SD) | Number of patients (%) | ||
| 9101 | 14.4 ± 13 | 632(13.7) | 5470 | 15.54 ± 14.7 | 352(16.6) | 3612 | 12.9 ± 10.3 | 280(11.2) | Neonatal | |
| 21329 | 21.35 ± 19.3 | 999(21.6) | 12490 | 24.3 ± 23.3 | 514(24.2) | 8847 | 18.24 ± 13.2 | 485(19.4) | NICU | |
| 8951 | 15.9 ± 17.9 | 563(12.2) | 5059 | 20.4 ± 24.1 | 248(11.7) | 3875 | 12.3 ± 9.4 | 315(12.6) | PICU | |
| - | 5179 | 6.3 ± 6.3 | 822(17.8) | 2225 | 5.98 ± 6.2 | 372(17.5) | 2952 | 6.56 ± 6.3 | 450(18) | Surgery |
| - | 11862 | 7.4 ± 7.5 | 1603(34.7) | 4582 | 7.17 ± 8.8 | 639(30.1) | 7269 | 7.54 ± 6.5 | 964(38.7) | Pediatrics |
| 0.66 | 56422 | 12.2 ± 14.3 | 4619(100) | 29826 | 14.03 ± 17.9 | 2125(100) | 26555 | 10.66 ± 9.96 | 2494(100) | Total |
Some antibiotics have significant different consumption in hot and cold seasons. For example, ampicillin and clindamycin were significantly more prescribed in spring and summer seasons, while vancomycin, ceftriaxone and imipenem were more frequently prescribed in fall & winter seasons. The total amount of antibiotics used was not significantly different in cold and hot seasons.
Considering the percent of patients received each antibiotic, ceftriaxone (44.8%), amikacin (14.8%) and ampicillin (14.5%) were the most common ones, while the least one was penicillin (0.2%) (Chart 1).
In both cold and warm seasons, Ceftriaxone was the most frequent prescribed antibiotic (Chart 1, Table 2).
Antibiotic usage in different wards of the hospital including NICU, PICU, Pediatric, Neonate and Surgery was shown in Table 2. Mean differences of day-stay in neonatal wards, NICU and PICU were significantly different between hot and cold seasons.
In both cold and warm seasons, Ceftriaxone was the most frequent prescribed antibiotic. In all different wards apart from NICU and neonatal wards, ceftriaxone had a highest DID level, whereas ampicillin was associated with the highest amount of DID level in both of them (Chart 1 and Table 2).
Antibiotics consumption in different wards based on DID
| Neonate | Surgery | NICU | PICU | Pediatrics | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total (P-value) | Spring & Summer | Fall & Winter | Total (P-value) | Spring & Summer | Fall & Winter | Total (P-value) | Spring & Summer | Fall & Winter | Total (P-value) | Spring &Summer | Fall & Winter | Total (P-value) | Spring &Summer | Fall & Winter | Antibiotic |
| 0.08(-) | 0 | 0.18 | 0(-) | 0 | 0 | 0.06(-) | 0 | 0.24 | 1.2 (-) | 0 | 1.91 | 0.20(-) | 0 | 0.34 | Amipicillin/Sulbactam (J01CR01) |
| 12.97(-) | 11.92 | 14.3 | 1.61(***) | 1.14 | 2.06 | 13.98(-) | 9.31 | 28.79 | 3.33(-) | 2.7 | 3.68 | 1.21(-) | 1.11 | 1.28 | Ampicillin (J01CA01) |
| 3.1(-) | 3.3 | 2.8 | 1.38(-) | 1.25 | 1.47 | 4.24(-) | 3.04 | 8.04 | 3.17(-) | 4.41 | 2.5 | 0.72(-) | 1.25 | 0.38 | Amikacin(J01GB06) |
| 0.12(-) | 0.15 | 0.08 | 0.14(-) | 0.19 | 0.08 | 0.53(-) | 0.44 | 0.81 | 1.35(-) | 0.79 | 1.67 | 1.01(-) | 0.13 | 0 | Imipenem (J01DH51) |
| 0(-) | 0 | 0 | 0.02(-) | 0.05 | 0 | 0(-) | 0 | 0 | 0.012(-) | 0 | 0.02 | 0.06 (**) | 0.04 | 0.078 | Procaine Penicillin (J01CE09) |
| 0(-) | 0 | 0 | 0.03(-) | 0.04 | 0.023 | 0.002(-) | 0.003 | 0 | 0.06(-) | 0.16 | 0 | 0.01(-) | 0.02 | 0 | Gentamicin (J01GB03) |
| 0.009(-) | 0 | 0.02 | 3.71(**) | 2.5 | 4.85 | 0(-) | 0 | 0 | 1.62(-) | 1.89 | 1.46 | 3.45(-) | 4.87 | 2.550 | Cefazolin (J01DB04) |
| 0.92(-) | 0.97 | 0.85 | 0.4(-) | 0 | 0.79 | 1.32(-) | 1.16 | 1.83 | 19.82(-) | 28.2 | 15.033 | 6.74(-) | 5.75 | 7.379 | Cefepime (J01DE01) |
| 0(-) | 0 | 0 | 0.78(-) | 0.77 | 0.79 | 0(-) | 0 | 0 | 0.41(-) | 1.13 | 0 | 0.15(-) | 0.137 | 0.16 | Ceftazidime(J01DD02) |
| 0.09(-) | 0.085 | 0.097 | 32.3(**) | 25.1 | 39.2 | 0(-) | 0 | 0 | 29.6(-) | 37.8 | 24.83 | 36.9(**) | 30.42 | 41.18 | Ceftriaxone(J01DD04) |
| 1.41(**) | 0.99 | 1.96 | 0.6(-) | 0.4 | 0.79 | 0.92(-) | 0.37 | 2.7 | 2.48(-) | 2.67 | 2.38 | 0.56(-) | 0.66 | 0.49 | Cefotaxime (J01DD01) |
| 0(-) | 0 | 0 | 0.58(-) | 1.18 | 0 | 0(-) | 0 | 0 | 8.68(-) | 14 | 5.6 | 1.87(-) | 3.81 | 0.6 | Clindamycin(J01FF01) |
| 0.53(-) | 0.52 | 0.54 | 0.56(-) | 0.38 | 0.73 | 1.47(-) | 1.03 | 2.85 | 9.59(-) | 9.93 | 9.4 | 0.61(-) | 0.23 | 0.9 | Meropenem (J01DH02) |
| 1.02(-) | 1.18 | 0.83 | 1.97(-) | 1.24 | 2.67 | 2.15(-) | 1.32 | 4.8 | 13.75(-) | 19.3 | 10.6 | 7.07(*) | 3.04 | 9.72 | Vancomycin(J01XA01) |
| 20.23 | 19.10 | 21.67 | 44.08 | 34.25 | 53.40 | 24.65 | 16.65 | 50.014 | 95.05 | 122.982 | 79.04 | 60.60 | 51.47 | 64.99 | Total |
| 1.45 | 1.36 | 1.55 | 3.14 | 2.44 | 3.81 | 1.76 | 1.18 | 3.57 | 6.78 | 8.78 | 5.65 | 4.32 | 3.67 | 4.65 | Mean |
Discussion
Our study shows overuse of antibiotics in our centre. Total DID of antibiotic usage is 46.32 DDD/100inh/day and some antibiotics like ceftriaxone and ampicillin have a very high DID numbers.
One of the advantages of our study is the comparison of antibiotic consumption in two different time periods (fall & winter Vs spring & summer). The result of this study demonstrates more admission and hospitalization days in neonatal, NICU and PICU wards in fall and winter. This may be related to the higher incidence of severe infectious diseases in the cold seasons, therefore more admission occurs in intensive care units.
Vancomycin, ceftriaxone and imipenem were more frequently prescribed in fall & winter seasons. It may be associated with more severe infectious disease and more resistant antibiotical pattern in cold seasons.
Several studies have shown the antibiotic utilization pattern in various hospitals around the world (18, 19). Systemic antibiotics were by far the most widely used drugs in children (20, 21). However, children differ from adults regarding pharmacokinetics and pharmcodynamics (6, 20, 22).
Different studies have been done on the pattern of antibiotics use in pediatric patients that has shown in Table 3. This shows the comparison of most common used antibiotics and DID number in different studies.
The comparison of most common used antibiotics and DID number in different studies.
| Different | Present | Italy, | Denmark, | Croatia, 2000[24] | Russia, | Italy, | Libya, 2008[17] | Libya , 2009[17] |
|---|---|---|---|---|---|---|---|---|
| Total inhabitants | 4207 | 22469 | 47173 | 6497 | 5467 | 215696 | 100 | 100 |
| Study setting | inpatient | outpatient | outpatient | inpatient | inpatient | outpatient | inpatient | inpatient |
| Most common used antibiotics: | Ceftriaxone | Amoxicillin+ enzyme inhibitor (2.3) | Phenoxymethyl- | Cefuroxime (6.8) | Amoxicillin (2.6) | Amoxicillin+ enzyme inhibitor (27%) | Amoxicillin+ enzyme inhibitor | Cloxacillin (0.9) |
| Total antibiotics DDD/100inh/day : | 46 | 6.7 | 3.5 | 29 | 8.3 | 119 | 3 | 6.4 |
Krivoy N, et al. (2007) has reported concern about the continuous and excessive use of antimicrobial agents that cause the emergence of antibiotic-resistant organisms. Evaluating antibiotic prescription and monitoring of antimicrobial uses are strategies recommended for management of resistance to antimicrobials in hospitalized patients. Also several studies report Antimicrobial resistance raises already-rising health care costs and increases patient morbidity and mortality(17, 25).
In our study, the most frequently used antibiotics were ceftriaxone 46.85%, ampicillin 13%, vancomycin 10.1%, cefepime 9%, amikacin 4.6%, and cefazolin 4%.
In the study of Katakam, et al. in pediatrics ward, Amoxicillin+Clavulanic acid (37%) and ampicillin (18%) were the most frequent prescribed antibiotics (17).
The least frequently used antibiotic was gentamicin in all duration of study. Due to concern regarding the resistance to Gentamicin, the high usage of amikacin in our center could be explained. In contrast to our study, Thrane et al. reported that penicillins were the most common antibiotics prescribed (26).
Drug consumption data were expressed as defined daily doses (DDD) per 100 inhabitants per day (DID). The highest value of ceftriaxone may imply that it was a choice as an empiric therapy in our hospital. In Katakam, et al., study ceftriaxone DDD/1000/Day was 2.6 in 2008 and 4 in 2009(17). In Resi, et al. study the most frequently used antibiotics were cephalosporins group (43.7% of treated children) and ceftriaxone was only 2.9% of total antibiotic used (6). Also, in our centre cephalosporins (63.7%) were the most prescribed antibiotics group but it was higher than other studies reports.
overuse of cephalosporins specially broad spectrum ones can cause the emergence of antimicrobial resistance and the overgrowth of pathogenic microorganisms(27, 28).
The present study demonstrated overuse of ceftriaxone apart from in neonate patients. Overuses and misuse of ceftriaxone and cefepime in our study, may lead to increases in antibiotic resistance.
According to the Gagliotti, et al. study, the most frequent antibiotic between 0-23 month years old was cephalosporin, but ceftriaxone had been prescribed in only 2.02% of all patients which is significantly lower than the results we have achieved in the present study(27).
According to the adverse effects of ceftriaxone especially in hyperbilirubinemic neonates and preterm babies, great potential for bilirubin displacement and developing kernicterus, the limited use of ceftriaxone in neonatal patients is predictable (29, 30).
Conclusion
The rate of antibiotics consumption in our setting was significantly higher than the other centers.
The high usage of Ceftriaxone, as a valuable third generation cephalosporin, was a prominent finding.
Strategies for more justified administration of antibiotics especially broad –spectrum ones are necessary.
Limitation
We measured antibiotics usage with adult DDDs number. It is notable that the previous studies in pediatrics do not estimate the DDD number in this population, so the methodology of our study were similar to other studies in this field.
Acknowledgements
References
-
1.
Kotwani A, Holloway K. Trends in Antibiotic Use Among Outpatients in New Delhi, India. BMC Infect. Dis. 2011;11:99. [PubMed ID: 21507212].
-
2.
Liem TB, Filius FM, van der Linden PD, Janknegt R, Natsch S, Vulto AG. Changes in antibiotic use in dutch hospitals over a 6-year period: 1997- 2002. Antimicrobial Drug Use in Hospitalized Children. 2011;63:60.
-
3.
Meyer E, Buttler J, Schneider C, Strehl E, Schroeren-Boersch B, Gastmeier P, Ruden H, Zentner J, Daschner FD, Schwab F. Modified guidelines impact on antibiotic use and costs: duration of treatment for pneumonia in a neurosurgical ICU is reduced. J. Antimicrob. Chemother. 2007;59:1148-1154. [PubMed ID: 17434880].
-
4.
Goldmann DA, Weinstein RA, Wenzel RP, Tablan OC, Duma RJ, Gaynes RP, Schlosser J, Martone WJ. Strategies to prevent and control the emergence and spread of antimicrobial-resistant microorganisms in hospitalsa challenge to hospital leadership. JAMA. 1996;275:234-240. [PubMed ID: 8604178].
-
5.
John JF, Fishman NO. Programmatic role of the infectious diseases physician in controlling antimicrobial costs in the hospital. Clin. Infec. Dis. 1997;24:471-485. [PubMed ID: 9114203].
-
6.
Resi D, Milandri M, Moro ML. Antibiotic prescriptions in children. J. Antimicrob. Chemother. 2003;52:282-286. [PubMed ID: 12865400].
-
7.
RÃnning M. Coding and classification in drug statistics from national to global application. Norsk Epidemiol. J. 2009:11.
-
8.
Alumran A, Hurst C, X-Y Hou. Antibiotics overuse in children with upper respiratory tract infections in Saudi Arabia: risk factors and potential interventions. Clin. Med. Diag. J. 2011;1:8-16.
-
9.
Huang SS, Rifas-Shiman SL, Kleinman K, Kotch J, Schiff N, Stille CJ, Steingard R, Finkelstein JA. Parental knowledge about antibiotic use: results of a cluster-randomized, multicommunity intervention. Pediatrics J. 2007;119:698-706.
-
10.
Kuster SP, Ruef C, Bollinger AK, Ledergerber B, Hintermann A, Deplazes C, Neuber L, Weber R. Correlation between case mix index and antibiotic use in hospitals. Antimicrob. Chemother. J. 2008;62:837-842.
-
11.
Newland JG, Banerjee R, Gerber JS, Hersh AL, Steinke L, Weissman SJ. Antimicrobial stewardship in pediatric care: strategies and future directions Pharmacother: Human Pharmacol. Drug Therapy J. 2012;32:735-743.
-
12.
Kuster SP, Ruef C, Ledergerber B, Hintermann A, Deplazes C, Neuber L, Weber R. Quantitative antibiotic use in hospitals: comparison of measurements, literature review, and recommendations for a standard of reporting. Infect. J. 2008;36:549-559.
-
13.
Kozyrskyj AL, Carrie AG, Mazowita GB, Lix LM, Klassen TP, Law BJ. Decrease in antibiotic use among children in the 1990s: not all antibiotics, not all children. Canadian Med. Assoc. J. 2004;171:133-138.
-
14.
Liem TB, Krediet TG, Fleer A, Egberts TC, Rademaker CM. Variation in antibiotic use in neonatal intensive care units in the Netherlands. J. Antimicrob. Chemother. 2010;65:1270-1275. [PubMed ID: 20375032].
-
15.
Vander Stichele RH, Elseviers MM, Ferech M, Blot S, Goossens H. Hospital consumption of antibiotics in 15 European countries: results of the ESAC Retrospective Data Collection (1997-2002). Antimicrob. Chemother. J. 2006;58:159-167.
-
16.
-
17.
Katakam P. A retrospective study on antibiotic use in different clinical departments of a teaching hospital in zawiya, libya. Ibnosina J. Med. Biomed. Sci. 2012;4:13-19.
-
18.
Kanerva M Ollgren J, LytikÃoinen O. Antimicrobial use in finnish acute care hospitals: data from national prevalence survey, 2005. Antimicrob. Chemother. J. 2007;60:440-444.
-
19.
Kritsotakis EI, Assithianakis P, Kanellos P, Tzagarakis N, Ioannides MC, Gikas A. Surveillance of monthly antimicrobial consumption rates stratified by patient-care area: a tool for triggering and targeting antibiotic policy changes in the hospital. J. Chemother. 2006;18:394-401. [PubMed ID: 17024795].
-
20.
Schirm E, van den Berg P, Gebben H, Sauer P, De Jong-van den Berg L. Drug use of children in the community assessed through pharmacy dispensing data. Br. J. Clin. Pharmacol. 2001;50:473-478. [PubMed ID: 11069442].
-
21.
Bonati M. Epidemiologic evaluation of drug use in children. Clin. Pharmacol. J. 1994;34:300-305.
-
22.
Walson PD Getschman S, Koren G. Principles of drug prescribing in infants and children. Drugs. 1993;46:281-288. [PubMed ID: 7691517].
-
23.
Lusini G, Lapi F, Sara B, Vannacci A, Mugelli A, Kragstrup J, Bjerrum L. Antibiotic prescribing in paediatric populations: a comparison between Viareggio, Italy and Funen, Denmark. Eur. J. Public Health. 2009;19:434-438. [PubMed ID: 19349289].
-
24.
Palcevski G, Ahel V, Vlahović-Palcevski V, Ratchina S, Rosovic-Bazijanac V, Averchenkova L. Antibiotic use profile at paediatric clinics in two transitional countries. Pharmacoepidemiol. Drug Safety. 2004;13:181-185.
-
25.
Ochoa C, Eiros JM, Inglada L, Vallano A, Guerra L. Assessment of antibiotic prescription in acute respiratory infections in adults The Spanish Study Group on Antibiotic Treatments. J. Infect. 2000;41:73-83. [PubMed ID: 10942644].
-
26.
Thrane N, Steffensen FH, Mortensen JT, Schønheyder HC, Sørensen HT. A population-based study of antibiotic prescriptions for Danish children. The Pediatric Inf. Dis. J. 1999;18:333-337.
-
27.
Gagliotti C, Morsillo F, Resi D, Milandri M, Moro ML. Antibiotic treatments for children ages 0-23 months in a northern Italy region: a cohort study. Infect. 2006;34:155-157.
-
28.
Mousavi S, Behi M, Taghavi MR, Ahmadvand A, Ziaie S, Moradi M. Drug utilization evaluation of imipenem and intravenous ciprofloxacin in a teaching hospital. Iran. J. Pharm. Res. 2013;12:161-167. [PubMed ID: 24250684].
-
29.
Lauer BJ, Spector ND. Hyperbilirubinemia in the Newborn. Pediatrics in Review. 2011;32:341-349. [PubMed ID: 21807875].
-
30.
Schellack N, Schellack G. Drug therapy in the neonate. Professional Nursing Today. 2010;14:5-17.